XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 148,699 $ 337,103
Marketable securities 202,663 402,870
Total cash, cash equivalents, and marketable securities 351,362 739,973
Accounts receivable, net 160,919 305,468
Unbilled receivables, net 175,732 173,085
Other current assets 123,791 115,178
Total current assets 811,804 1,333,704
Long-term unbilled receivables, net 105,863 61,407
Goodwill 81,402 81,113
Other long-term assets 293,717 292,049
Total assets 1,292,786 1,768,273
Current liabilities:    
Accounts payable 8,057 6,226
Accrued expenses 51,857 31,544
Accrued compensation and related expenses 111,650 138,042
Deferred revenue 404,757 423,910
Convertible senior notes, net 0 467,470
Other current liabilities 21,131 18,866
Total current liabilities 597,452 1,086,058
Long-term operating lease liabilities 62,402 67,647
Other long-term liabilities 36,102 29,088
Total liabilities 695,956 1,182,793
Commitments and contingencies (Note 17)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 400,000 shares authorized; 170,545 and 172,224 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 1,705 1,722
Additional paid-in capital 370,018 526,102
Retained earnings 233,925 87,901
Accumulated other comprehensive (loss) (8,818) (30,245)
Total stockholders’ equity 596,830 585,480
Total liabilities and stockholders’ equity $ 1,292,786 $ 1,768,273